Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-1 up-regulation on CD4 + T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
Lindsay J. Celada, Jonathan A. Kropski, José D. Herazo-Maya, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 460
Open Access | Times Cited: 297

Showing 1-25 of 297 citing articles:

Transforming growth factor–β in tissue fibrosis
Nikolaos G. Frangogiannis
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 3
Open Access | Times Cited: 858
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou, Qiyu Tong, Bowen Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 736
Immune-checkpoint inhibitors: long-term implications of toxicity
Douglas B. Johnson, Caroline A. Nebhan, Javid J. Moslehi, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 4, pp. 254-267
Open Access | Times Cited: 664
Shared and distinct mechanisms of fibrosis
Jörg H. W. Distler, Andrea‐Hermina Györfi, Meera Ramanujam, et al.
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 12, pp. 705-730
Closed Access | Times Cited: 468
Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map
Jennifer Huynh, Ashwini L. Chand, Daniel J. Gough, et al.
Nature reviews. Cancer (2018) Vol. 19, Iss. 2, pp. 82-96
Closed Access | Times Cited: 453
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
B.J. Moss, Stefan W. Ryter, Iván O. Rosas
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 515-546
Closed Access | Times Cited: 438
Sarcoidosis
Johan Grünewald, Jan C. Grutters, Elizabeth V. Arkema, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 381
Challenges of Sarcoidosis and Its Management
Marjolein Drent, Elliott D. Crouser, Johan Grünewald
New England Journal of Medicine (2021) Vol. 385, Iss. 11, pp. 1018-1032
Closed Access | Times Cited: 279
Immune dysregulation as a driver of idiopathic pulmonary fibrosis
Kevin Shenderov, Samuel L. Collins, Jonathan D. Powell, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 2
Open Access | Times Cited: 205
Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times
Christian Bailly, Xavier Thuru, Bruno Quesnel
NAR Cancer (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 202
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
Paolo Spagnolo, Oliver Distler, Christopher J. Ryerson, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 2, pp. 143-150
Open Access | Times Cited: 177
Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches
Innokenty A. Savin, Marina A. Zenkova, Aleksandra V. Sen’kova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14959-14959
Open Access | Times Cited: 125
Lung microbiome: new insights into the pathogenesis of respiratory diseases
Ruomeng Li, Jing Li, Xikun Zhou
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 119
Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway
Yuying Wang, Xi Wang, Yixuan Li, et al.
Pharmacological Research (2022) Vol. 176, pp. 106083-106083
Open Access | Times Cited: 89
Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis
Kota Kokubo, Atsushi Onodera, Masahiro Kiuchi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation
Thomas Krausgruber, Anna Redl, Daniele Barreca, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 289-306.e7
Open Access | Times Cited: 71
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
John A. Mackintosh, Gregory J. Keir, Lauren Troy, et al.
Respirology (2024) Vol. 29, Iss. 2, pp. 105-135
Open Access | Times Cited: 25
Epigenetic Targets and Their Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
Xiaohui Miao, Pan Liu, Yangyang Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117463-117463
Closed Access | Times Cited: 2
Interleukin-36γ–producing macrophages drive IL-17–mediated fibrosis
Sven D. Sommerfeld, Christopher Cherry, Remy Schwab, et al.
Science Immunology (2019) Vol. 4, Iss. 40
Open Access | Times Cited: 142
Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer
Αrgyris Τzouvelekis, Georgia Gomatou, Evangelos Bouros, et al.
CHEST Journal (2019) Vol. 156, Iss. 2, pp. 383-391
Closed Access | Times Cited: 124
PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis
Yan Geng, Xue Liu, Jiurong Liang, et al.
JCI Insight (2019)
Open Access | Times Cited: 107
Microglial priming of antigen presentation and adaptive stimulation in Alzheimer’s disease
Rashmi Ranjan Das, Subashchandrabose Chinnathambi
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 19, pp. 3681-3694
Closed Access | Times Cited: 105
IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages
Lizong Rao, Yi Wang, Lei Zhang, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 4, pp. 1270-1283
Open Access | Times Cited: 104
Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity
Lu Cui, Shih‐Yu Chen, Tristan Lerbs, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 99
Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases
Christian Bailly, Xavier Thuru, Bruno Quesnel
Cancers (2021) Vol. 13, Iss. 12, pp. 3034-3034
Open Access | Times Cited: 97
Page 1 - Next Page

Scroll to top